Luckwel Pharmaceuticals Inc. (OTCPK:LWEL) entered into subscription agreement for a private placement of 187,500 restricted shares, par value $0.01 per share, at a price of $0.40 per share for gross proceeds of $75,000 on May 14, 2021. The transaction will include participation from Bounty Company Limited. The transaction is expected to close on or around May 29, 2021. The shares have been registered under the Securities Act of 1933.